Engineered blood vesicles improve memory in Alzheimer mice

Cells constantly communicate through small packages called exosomes that they release into the body. These vesicles carry proteins and other molecules and are taken up by nearby or distant cells. Scientists have long explored exosomes as a potential tool against brain diseases. The core problem is that they struggle to cross the blood-brain barrier: the dense cellular layer that protects the brain from substances circulating in the blood.

A targeting molecule on the surface

The researchers attached a molecule derived from the rabies virus (RVG-29) to the outside of exosomes harvested from young blood plasma. This molecule acts as a key that helps the vesicles pass through the blood-brain barrier and deliver their cargo directly to neurons. In mice modelling Alzheimer’s disease, the treatment led to noticeable improvements in spatial learning, working memory, and novel object recognition. The study was published in Bioactive Materials.

Fewer plaques, more healthy cells

Brain tissue from treated mice showed reduced accumulation of amyloid-beta, the protein that forms the characteristic plaques of Alzheimer’s disease. Excessive activation of tau protein, another hallmark of the condition, also decreased. Neuron counts increased and the balance between inhibitory and excitatory neurons was partially restored. These findings come entirely from a mouse model. Whether the approach works in humans is entirely unknown and requires further research.

For longevity science, the underlying mechanism is notable: if exosomes from young blood carry protective signals, engineering those vesicles may offer a path to supporting the aging brain even before the full signaling landscape is understood.

Read the original article